WP
HOOK

Woodline Partners’s HOOKIPA Pharma HOOK Stock Holding History

Woodline Partners’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-67,475
Closed -$3.97M – 740
2021
Q3 		$3.97M Sell
67,475
-22,685
-25% -$1.65M 0.06% 291
2021
Q2 		$8.26M Buy
90,160
+22,134
+33% +$2.95M 0.15% 155
2021
Q1 		$9.15M Buy
+68,026
New +$8.21M 0.2% 126

Other funds holding HOOK

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodline Partners's HOOK Position: Q4 2021 in Review

Woodline Partners sold out of HOOKIPA Pharma (HOOK) in Q4 2021, closing a stake of 67,475 shares — an estimated $3.97M sold.

Woodline Partners first reported a position in HOOK in Q1 2021 and held it in 3 quarters. The position peaked at $9.15M in Q1 2021. 72 funds tracked by Wall St. Rank hold HOOK as of Q4 2021.

  • Woodline Partners reported no remaining HOOKIPA Pharma position as of Q4 2021 after selling out during the quarter.
  • Woodline Partners sold 67,475 HOOKIPA Pharma shares in Q4 2021, an estimated $3.97M.
  • Woodline Partners first reported a position in HOOKIPA Pharma in Q1 2021 and held it in 3 quarters.
  • Woodline Partners's HOOKIPA Pharma position peaked at $9.15M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2021.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.